Canada's Pharmaceutical Industry - Porter’s Five Forces Strategy Analysis

Canada's Pharmaceutical Industry - Porter’s Five Forces Strategy Analysis


October 1, 2011
35 Pages - SKU: ARVN6581697
License type:
Online Download      US $200.00
Global Site License      US $400.00
Countries covered: Canada

Pharmaceutical is one of the most intense “Knowledge Driven” industries, which is continually in a state of dynamic transition.Diversities in life forms and diseases pose stiff challenge to the design of specific and targeted solutions. The process of “drug discovery/invention” is elaborate requiring on an average 8-10 years at a cost of US$ 300 million to reach a new drug to the market.

Aruvian's R'search analyzes Canada's Pharmaceutical Industry in the Michael Porter’s Five Forces Analysis. It uses concepts developed in Industrial Organization (IO) economics to derive five forces that determine the competitive intensity and therefore attractiveness of a market. Porter referred to these forces as the microenvironment, to contrast it with the more general term macroenvironment. They consist of those forces close to a company that affect its ability to serve its customers and make a profit. A change in any of the forces normally requires a company to re-assess the marketplace.



More Drug Discovery reports by Aruvian's R'search

Pharmaceutical Industry in the United States - Porter’s Five Forces Strategy Analysis by Aruvian's R'search
Pharmaceutical Industry in the United States - Porter’s Five Forces Strategy AnalysisPharmaceutical is one of the most intense “Knowledge Driven” industries, which is continually in ...
Pharmaceutical Industry in the United States - Porter’s Five Forces Strategy Analysis by Aruvian's R'search
Pharmaceutical is one of the most intense “Knowledge Driven” industries, which is continually in a state of dynamic transition.Diversities in life forms and diseases pose ...
US Pharmaceutical Industry – PEST Framework Analysis by Aruvian's R'search
Pharmaceutical is one of the most intense “Knowledge Driven” industries, which is continually in a state of dynamic transition. Diversities in life forms and diseases ...
Analyzing the Global CNS Market by Aruvian's R'search
The CNS market at a global scale is one of the largest and fastest growing markets in the pharmaceutical industry. Reimbursement terms remain favorable within ...
See all reports like this >>

More Canada Drug Discovery reports

PharmaPoint: Crohn’s Disease - Canada Drug Forecast and Market Analysis to 2022 by GlobalData
PharmaPoint: Crohn’s Disease - Canada Drug Forecast and Market Analysis to 2022SummaryThe Crohn’s disease (CD) market is currently very dynamic, with novel biologic therapies on ...
PharmaPoint: Obesity - Canada Drug Forecast and Market Analysis to 2022 by GlobalData
PharmaPoint: Obesity - Canada Drug Forecast and Market Analysis to 2022SummaryAfter a more than decade long dormancy, the Obesity market is undergoing a revival with ...
PharmaPoint: Multiple Sclerosis - Canada Drug Forecast and Market Analysis to 2022 by GlobalData
PharmaPoint: Multiple Sclerosis - Canada Drug Forecast and Market Analysis to 2022SummaryGlobalData has released its new Country report, “PharmaPoint: Multiple Sclerosis - Canada Drug Forecast ...
Multiple Sclerosis - Canada Drug Forecast and Market Analysis to 2022 by GlobalData
PharmaPoint: Multiple Sclerosis - Canada Drug Forecast and Market Analysis to 2022SummaryGlobalData has released its new Country report, “PharmaPoint: Multiple Sclerosis - Canada Drug Forecast ...
See all reports like this >>

More Canada reports

D&B Country RiskLine Report: Canada by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
D&B Country Report: Canada by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
See all reports like this >>